Correction: Omalizumab in Severe Allergic Asthma
- PMID: 31569247
- DOI: 10.7326/L19-0549
Correction: Omalizumab in Severe Allergic Asthma
Erratum for
-
Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.Ann Intern Med. 2011 May 3;154(9):573-82. doi: 10.7326/0003-4819-154-9-201105030-00002. Ann Intern Med. 2011. PMID: 21536936 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources